Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease
Brent A. Neuschwander‐Tetri
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 411

Showing 1-25 of 411 citing articles:

Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3319
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara, Scott L. Friedman, Nicolas Goossens, et al.
Journal of Hepatology (2017) Vol. 68, Iss. 3, pp. 526-549
Open Access | Times Cited: 604
Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output
Qiyi Zhao, Jiayu Liu, Hong Deng, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 76-93.e22
Open Access | Times Cited: 333
Obesity and nonalcoholic fatty liver disease: current perspectives
Raiya Sarwar, Nicholas Pierce, Sean Koppe
Diabetes Metabolic Syndrome and Obesity (2018) Vol. Volume 11, pp. 533-542
Open Access | Times Cited: 218
Therapeutic Landscape for NAFLD in 2020
Brent A. Neuschwander‐Tetri
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1984-1998.e3
Closed Access | Times Cited: 168
Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease
Chander K. Negi, Pavel Babica, Lola Bajard, et al.
Metabolism (2021) Vol. 126, pp. 154925-154925
Open Access | Times Cited: 163
Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects
Basil Alawyia, Constantina Constantinou
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 7, pp. 711-724
Closed Access | Times Cited: 71
Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
Yuxin Yao, Yujie Yu, Shu Dai, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116694-116694
Open Access | Times Cited: 17
Lubiprostone Reduces Fat Content on MRI‐PDFF in Patients With MASLD: A 48‐Week Randomised Controlled Trial
Mohamed El‐Kassas, Hala Mostafa, Wessam Abdellatif, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 4
Integrated bioinformatics and multi-omics to investigate the mechanism of Rhododendron molle Flos-induced hepatotoxicity
Qiang Ran, Mengjun Huang, Lijuan Wang, et al.
Journal of Ethnopharmacology (2025) Vol. 341, pp. 119308-119308
Closed Access | Times Cited: 3
Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet
Chian‐Jiun Liou, Yau-Ker Lee, Nai‐Chun Ting, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 447-447
Open Access | Times Cited: 137
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
K.S. Tølbøl, Maria Nicoline Baandrup Kristiansen, Henrik H. Hansen, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 2, pp. 179-194
Open Access | Times Cited: 116
Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease
Kathy Musa‐Veloso, Carolina Venditti, Han Youl Lee, et al.
Nutrition Reviews (2018) Vol. 76, Iss. 8, pp. 581-602
Open Access | Times Cited: 103
Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial
Yang Chen, Rennan Feng, Xue Yang, et al.
American Journal of Clinical Nutrition (2019) Vol. 109, Iss. 6, pp. 1611-1619
Open Access | Times Cited: 96
Autophagy and oxidative stress in non-communicable diseases: A matter of the inflammatory state?
Daniel Peña‐Oyarzún, Roberto Bravo, Alexis Díaz‐Vegas, et al.
Free Radical Biology and Medicine (2018) Vol. 124, pp. 61-78
Closed Access | Times Cited: 87
Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
Paria Zarghamravanbakhsh, Michael Frenkel, Leonid Poretsky
Metabolism Open (2021) Vol. 12, pp. 100149-100149
Open Access | Times Cited: 87
Impacts of exercise intervention on various diseases in rats
Ruwen Wang, Haili Tian, Dandan Guo, et al.
Journal of sport and health science/Journal of Sport and Health Science (2019) Vol. 9, Iss. 3, pp. 211-227
Open Access | Times Cited: 82
The metabolic basis of nonalcoholic steatohepatitis
Manu V. Chakravarthy, Brent A. Neuschwander‐Tetri
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 4
Open Access | Times Cited: 79
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
Ming‐Chao Tsai, Yu-Yin Liu, Chih‐Che Lin, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 820-820
Open Access | Times Cited: 77
Microbial Metabolites: Critical Regulators in NAFLD
Xin Dai, Huiqin Hou, Wanru Zhang, et al.
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 77
Is Fatty Liver Associated With Depression? A Meta-Analysis and Systematic Review on the Prevalence, Risk Factors, and Outcomes of Depression and Non-alcoholic Fatty Liver Disease
Jieling Xiao, Lincoln Kai En Lim, Cheng Han Ng, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 69
Oxidative Stress, Genomic Integrity, and Liver Diseases
Nanthini Sadasivam, Yu‐Ji Kim, Kamalakannan Radhakrishnan, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3159-3159
Open Access | Times Cited: 63
Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
Xian-min Dai, Jiayi Feng, Yi Chen, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 60
Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population
Rongsheng Wang, Longlong Dai, Yanjia Zhong, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 59
Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?
Gabriel Tayguara Silveira Guerreiro, Larisse Longo, Mariana Fonseca, et al.
Hepatology International (2021) Vol. 15, Iss. 2, pp. 380-391
Closed Access | Times Cited: 58
Page 1 - Next Page

Scroll to top